Commencing 8 November 2021, the United States of America will lift Covid-19 travel restrictions for fully vaccinated travellers from across the world, including Indians. This move opens the curtains for travellers from many countries to visit the US after 21 months of restrictions forced due to Covid 19.
“Starting November 8, the United States will admit fully vaccinated foreign air travellers from the 26 so-called Schengen countries in Europe, including France, Germany, Italy, Spain, Switzerland and Greece, as well as Britain, Ireland, China, India, South Africa, Iran and Brazil”, the official White House order stated.
Though the US council has not announced anything concerning travel-specific guidelines. The Centers for Disease Control and Prevention (CDD) has announced, the international travellers, who are fully vaccinated by vaccines approved by the FDA, as well as WHO, will be accepted for entry into the United States.
Oxford/AstraZeneca’s AZD1222; Sinopharm’s BBIBP-CorV (Vero Cells); Pfizer/BioNTech’s BNT162b2; Johnson & Johnson’ Ad26; COV2.S; Moderna’s m-RNA-1273; Serum Institute of India’s Covishield; Sinopharm’s BBIBP-CorV (Vero Cells), and Sinovac’s CoronaVac, are the seven vaccines that are officially approved by WHO.
“Individuals who have any combination of two doses of an FDA approved/authorized or WHO emergency use listed COVID-19 two-dose series are considered fully vaccinated,” the CDC added.
Also, nearly 50 countries have approved the Serum Institute’s Covishield vaccine, which is primarily used in India. And as per the reports, Indians who have taken either Covaxin or Sputnik will not be able to travel to the US next month.
However, 50 countries including – The US, the UK, Afghanistan, Antigua and Barbuda, Argentine, Bahamas, Bahrain, Bangladesh, Barbados, Bhutan, Bolivia, Botswana, Brazil, Cabo Verde, Canada, Côte d’Ivoire, Dominica, Egypt, Ethiopia, Ghana, Grenada, Honduras, Hungary, Jamaica, Lebanon, Madagascar, Maldives, Morocco, Myanmar, Namibia, Nepal, Nicaragua, Nigeria, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Seychelles, Somalia, South Africa, Sri Lanka, Suriname, Syrian Arab Republic, Togo, Tonga, Trinidad and Tobago, and Ukraine, have approved the Serum Institute’s Covishield vaccine, according to the WHO.